STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its upcoming participation at the TD Cowen 45th Annual Health Care Conference. The presentation is scheduled for Monday, March 3, 2025, at 10:30 a.m. ET.

The company will provide a live webcast of the conference presentation, which will be accessible through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. Interested parties who cannot attend the live presentation will have access to a replay of the webcast for approximately 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Meredith Kaya 
meredith.kaya@apellis.com
617.599.8178


FAQ

When is Apellis Pharmaceuticals (APLS) presenting at the TD Cowen Healthcare Conference 2025?

Apellis Pharmaceuticals (APLS) will present at the TD Cowen Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET.

How long will the APLS TD Cowen conference webcast replay be available?

The webcast replay will be available for approximately 90 days following the March 3, 2025 presentation.

Where can investors watch Apellis' (APLS) TD Cowen conference presentation?

Investors can watch the presentation through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website.

What type of event is APLS participating in on March 3, 2025?

APLS is participating in the TD Cowen 45th Annual Health Care Conference, where they will give a company presentation.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.81B
106.61M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM